Organization 【 display / non-display

  • 2014.10.01 - 2015.02.28, Division of Medicine, Graduate School of Medicine, Assistant Professor

  • 2015.03.01 - , Division of Medicine, Graduate School of Medicine, Assistant Professor

 

Academic Papers 【 display / non-display

  • Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer., Makino T, Yamasaki M, Tanaka K, Masuike Y, Tatsumi M, Motoori M, Kimura Y, Hatazawa J, Mori M, Doki Y, Annals of surgery,270(6) 1090-1095, 2019.12, Papers

  • Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer., Taniguchi Y, Kurokawa Y, Takahashi T, Mikami J, Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Nakajima K, Mori M, Doki Y, World journal of surgery,42(12) 3997-4004, 2018.12, Other

  • SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling., Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Nishida T, Hirota S, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanasaki K, Kishimoto T, Mori M, Doki Y, Naka T, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,21(6) 968-976, 2018.11, Other

  • Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy., Kanemura T, Miyata H, Makino T, Tanaka K, Sugimura K, Hamada-Uematsu M, Mizote Y, Uchida H, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Wada H, Nakajima K, Takiguchi S, Mori M, Doki Y, Tahara H, Cancer science,109(11) 3393-3402, 2018.11, Other

  • [II. Treatment Strategy for Esophagogastric Junction Tumor]., Hashimoto T, Kurokawa Y, Miyazaki Y, Takahashi T, Tanaka K, Makino T, Yamazaki M, Nakajima K, Mori M, Doki Y, Gan to kagaku ryoho. Cancer & chemotherapy,45(9) 1248-1253, 2018.09, Other

display all >>